Summit Therapeutics (SMMT) shares fell 37%, or $13.49, to $23.21 before halting for news. BioNTech (BNTX) dropped in sympathy, down 15% to $102.85.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMT: